On Demand Webinar

Accelerate IO Drug Development with a Fast, Cost-effective, and Powerful Screening Tool

In this webinar Dr. Bailey Zhong will discuss common immuno-oncology (IO) drug development challenges and how a large-scale in vivo screen can be used to overcome these challenges.

You can also participate in an interactive Q&A session to have your most pressing questions answered.

Watch Now

You'll learn about:

• How this platform enables clients to efficiently determine how to progress their preclinical drug development efforts or conduct early-stage drug screening.
  
  
• The different immuno-oncology models offered in MuScreen^TM that fit specific application scenarios due to their unique features.
  
  
• Why MuScreen’s model panel offers an ideal range of IO interactions, supporting mechanism of action studies.
  
  
• How the panel is highly capable of discovering IO biomarkers when used in conjunction with downstream analysis.

Watch Now

Watch Now!

About the Presenter:

Bailey Zhong, PhD, Senior Manager of Scientific Engagement, Crown Bioscience (APAC regions)

Bailey (Yixiang) Zhong is the Senior Manager of Scientific Engagement for the APAC territory at Crown Bioscience. He specializes in providing IND-facing pharmacological solutions for new cancer drugs, as well as pre-clinical efficacy and MOA assays. Bailey joined Crown Bioscience after completing his PhD and post-doctoral training at Hanyang University in Korea. With ten years of research experience in multiple life science fields, including oncology, stem cell, organoid, and bioinformatics, Bailey has led over 150 external studies at Crown Bioscience and contributed to more than 30 sponsors’ IND/CTA submission projects. He has also published 5 peer-reviewed scientific articles. Bailey’s expertise and experience make him a valuable asset to the Crown Bioscience team.